Chinese export of active pharmaceutical ingredients has been complicated by pandemic-related supply-chain chaos and, more recently, the lifting of the country’s zero-COVID policy.
Cost of China-made drug ingredients more than doubled during pandemic
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Caregiver stress lessened after pandemic lockdowns lifted, study finds
- Dip in alcohol consumption in early pandemic linked to less social drinking
- High-risk patients with COVID symptoms should use PCR rather than rapid tests, study suggests
- Peer support valuable intervention for health worker stress during COVID-19, study shows